ChrysCapital-backed Intas Pharmaceuticals could scrap IPO amid market volatility

ChrysCapital-backed Indian drug maker Intas Pharmaceuticals is reportedly considering scrapping its public listing amid decade-low IPO valuations in the country due to the fallout from political gridlock.